Business Insider

Bio-Techne Announces Launch of Professional Assay Services - Dedicated Source for RNA in situ Hybridization Assays in Spatial Gene Expression Analysis

MINNEAPOLIS, April 15, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne brand, completed an extensive rebranding effort in ...
GEN

Singling Out RNA Biomarkers in Situ

Advanced Cell Diagnostics (ACD), a company recently acquired by Bio-Techne, has introduced assays that promise to transform molecular pathology. These assays can detect and quantify RNA in situ while ...

In Situ Hybridization Markets and Company Analysis 2025-2033: Shares Data for Products, Techniques, Applications, End Users, Countries

The "In Situ Hybridization Market Report by Product, Technique, Application, End User, Countries and Company Analysis ...
Nasdaq

Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument

MINNEAPOLIS, April 2, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced an expansion of the longstanding partnership between its spatial biology brand, Advanced Cell ...
The Scientist

Genetic Variant Detection in Cancer: Using ISH to Track Tumor Evolution

Genetic Variant Detection in Cancer: Using ISH to Track Tumor Evolution from thescientistllc on Vimeo. Intratumor heterogeneity (ITH) is a major underlying cause of therapy resistance and disease ...